Skip to main content

Table 2 Demographic data and participants’ results for clinical outcomes

From: Comparison of walking variations during treadmill walking test between neurogenic and vascular claudication: a crossover study

 

LSS group

(n = 23)

PAD group

(n = 14)

nLBP group

(n = 18)

p-value

F:M

9:14

5:9

10:8

N/A

Age (years)

70.00 ± 7.66

72.43 ± 9.41

52.00 ± 9.29

< 0.001*†

Weight (kg)

82.02 ± 14.76

83.20 ± 22.15

82.26 ± 9.95

0.975

Height (m)

1.68 ± 0.09

1.89 ± 0.80

1.69 ± 0.07

0.265

BMI (kg/m2)

29.02 ± 4.05

27.65 ± 9.02

28.85 ± 3.51

0.756

Leg pain intensity in the past week (/10)

5.63 ± 2.19

6.04 ± 2.06

3.74 ± 2.33

0.008*†

WIQdistance (%)

34.91 ± 30.30

24.34 ± 31.62

89.54 ± 17.97

0.001*†

WIQspeed (%)

31.00 ± 20.49

23.99 ± 24.33

75.24 ± 20.67

< 0.001* †

WIQstairs (%)

20.92 ± 14.51

15.19 ± 15.82

41.88 ± 10.66

< 0.001* †

WIQmean (%)

28.94 ± 20.52

21.17 ± 22.87

68.89 ± 14.20

< 0.001* †

FC-SSSQpain (/35)

20.87 ± 4.25

21.86 ± 3.46

14.17 ± 4.00

< 0.001* †

FC-SSSQfunction (/20)

11.96 ± 2.85

12.00 ± 4.22

7.39 ± 2.89

0.001* †

FC-SSSQtotal (/55)

33.26 ± 6.29

33.86 ± 6.01

21.56 ± 5.38

< 0.001* †

TSK (/68)

45.43 ± 8.39

38.46 ± 8.13

34.39 ± 7.91

< 0.001*#

EQ-VAS score (/100)

73.00 ± 18.38

66.79 ± 18.18

78.44 ± 6.78

0.118

  1. * p < 0.001 between the LSS group and the nLBP group
  2. p < 0.001 between the PAD group and the nLBP group
  3. # p < 0.05 between the LSS group and the PAD group
  4. LSS: Lumbar Spinal Stenosis, PAD: Peripheral Arterial Disease, nLBP: non-specific Low Back Pain, F: female, M: male, BMI: Body Mass Index, WIQ: Walking Impairment Questionnaire, FC-SSSQ: French-Canadian Swiss Spinal Stenosis Questionnaire, TSK: Tampa Scale of Kinesiophobia, EQ-VAS score: EQ-5D: European Questionnaire– 5 dimensions Visual Analog Scale